NATIONAL NEOPLASTIC DISEASE INSITUTE (INEM) IN LIMA HOSTED THE BIANNUAL SELNET CONSORTIUM ON APRIL 28-29TH
The National Neoplastic Disease Institute (INEM) from Lima (Peru) hosted the 7th SELNET consortium last April 28 & 29th. Inaugurated by the General Manager of INEM Dr. Eduardo Payet Meza and the principal investigator of SELNET in Peru, Dr. Victor Castro, the 2-day meeting aimed to overview across the most relevant details of the 10 work packages that are being conducted by SELNET consortium.
Representative researchers from almost all 53 Institutions that currently are networking in SELNET actively participated in the discussions. The SELNET clinical practice guideline (CPG) adoption for Peruvian context was started in this meeting. Some emerging issues were more apparent in the discussion of the CPG as the need to modulate timings. This was a very fruitful and pragmatical meeting that will entail transforming actions which will be directly translated into the sarcoma management in Peru. We are very thankful to Peruvian host team, especially to Milagros Arteaga, Macarena Farias, Juan Carlos Haro, Martín Falla, Darwin Salazar, and Tatiana Vidaurre for their commitment and kind handling. This was the first hybrid (on-site and online) SELNET meeting after the pandemic, and this was an outstanding fact in the attitude of all the participants.
The new building of INEM was spectacular, maybe the most striking aspect was that 3 floors were dedicated to day Hospital. This outpatient care program is equipped with more than 250 seats/booths for systemic administration of antineoplastic drugs. This huge facility is the largest oncology Day Hospital I have ever seen.
The teaching program was also relevant, and speakers as Emanuela Palmerini, Robert Maki, Dario Callagaro, Matias Chacon, Salvatore Provenzano, Paolo DeiTos, Alberto Righi and Nadia Hindi, among others, gave important insights in different sarcoma scenarios. Additionally, GEIS and SPAEN representatives, Dr. Claudia Valverde and Matias Muñoz also contributed to the success of the meeting.
In upcoming dates, the final adoption of CPG for Peru will be a reality, and we recommend that MDT discussion among doctors from different sarcoma hospitals in Peru will be scheduled for this important achievement.
Thanks to Peruvian Colleagues for this unforgettable time.
